ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
3,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
3,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
4,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
5,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
5,2,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
6,1,Fertility increased,Endocrine abnormalities of gonadal function NEC,Endocrine disorders of gonadal function,Endo,N
6,2,Herbal interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6,3,Pregnancy on oral contraceptive,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
7,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
